title: Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence.
abstract: The vaccinia virus (VACV) strain Western Reserve C16 protein has been characterized and its effects on virus replication and virulence have been determined. The C16L gene is present in the inverted terminal repeat and so is one of the few VACV genes that are diploid. The C16 protein is highly conserved between different VACV strains, and also in the orthopoxviruses variola virus, ectromelia virus, horsepox virus and cowpox virus. C16 is a 37.5 kDa protein, which is expressed early during infection and localizes to the cell nucleus and cytoplasm of infected and transfected cells. The loss of the C16L gene had no effect on virus growth kinetics but did reduce plaque size slightly. Furthermore, the virulence of a virus lacking C16L (vDeltaC16) was reduced in a murine intranasal model compared with control viruses and there were reduced virus titres from 4 days post-infection. In the absence of C16, the recruitment of inflammatory cells in the lung and bronchoalveolar lavage was increased early after infection (day 3) and more CD4(+) and CD8(+) T cells expressed the CD69 activation marker. Conversely, late after infection with vDeltaC16 (day 10) there were fewer T cells remaining, indicating more rapid clearance of infection. Collectively, these data indicate that C16 diminishes the immune response and is an intracellular immunomodulator.
authors.affiliation: Department of Virology, Faculty of Medicine, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.
authors.forename: Aodhnait S
authors.initials: AS
authors.lastname: Fahy
authors.affiliation: Department of Virology, Faculty of Medicine, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.
authors.forename: Richard H
authors.initials: RH
authors.lastname: Clark
authors.affiliation: Department of Virology, Faculty of Medicine, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.
authors.forename: Emily F
authors.initials: EF
authors.lastname: Glyde
authors.affiliation: Department of Virology, Faculty of Medicine, Imperial College London, St Mary's Campus, Norfolk Place, London W2 1PG, UK.
authors.forename: Geoffrey L
authors.initials: GL
authors.lastname: Smith
mesh_terms: D000281:Administration, Intranasal; D000818:Animals; D002460:Cell Line; D002467:Cell Nucleus / Q000378:metabolism; D003593:Cytoplasm / Q000378:metabolism; D004195:Disease Models, Animal; D005260:Female; D017353:Gene Deletion; D005786:Gene Expression Regulation; D006367:HeLa Cells; D054884:Host-Pathogen Interactions; D006801:Humans; D007271:Injections, Intradermal; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D014615:Vaccinia / Q000276:immunology* / Q000503:physiopathology / Q000821:virology; D014616:Vaccinia virus / Q000235:genetics / Q000472:pathogenicity* / Q000502:physiology; D014759:Viral Envelope Proteins / Q000235:genetics / Q000378:metabolism*; D014774:Virulence
chemical_list: D008565:Membrane Proteins; D014759:Viral Envelope Proteins; C084759:p37 protein, Vaccinia virus
references.citation: PLoS Pathog. 2008 Feb 8;4(2):e22
references.pmid: 18266467
references.citation: Cell. 1992 Oct 2;71(1):153-67
references.pmid: 1394428
references.citation: Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10162-7
references.pmid: 10920188
references.citation: J Gen Virol. 2000 May;81(Pt 5):1223-30
references.pmid: 10769064
references.citation: J Gen Virol. 2002 Nov;83(Pt 11):2833-2844
references.pmid: 12388820
references.citation: Proc Natl Acad Sci U S A. 1983 Sep;80(17):5364-8
references.pmid: 6310573
references.citation: J Virol. 2005 Jan;79(2):966-77
references.pmid: 15613325
references.citation: Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4825-9
references.pmid: 1350676
references.citation: Acta Biochim Pol. 2004;51(1):57-66
references.pmid: 15094825
references.citation: Parasitology. 2005;130 Suppl:S11-25
references.pmid: 16281988
references.citation: J Gen Virol. 1997 Mar;78 ( Pt 3):677-85
references.pmid: 9049422
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2140-5
references.pmid: 18245380
references.citation: J Virol. 2003 Sep;77(18):9960-8
references.pmid: 12941906
references.citation: Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):11029-34
references.pmid: 8855303
references.citation: J Gen Virol. 1999 Oct;80 ( Pt 10):2751-2755
references.pmid: 10573171
references.citation: J Immunol. 1995 Nov 1;155(9):4467-75
references.pmid: 7594609
references.citation: J Gen Virol. 2002 Aug;83(Pt 8):1965-1976
references.pmid: 12124460
references.citation: Virology. 1988 May;164(1):182-92
references.pmid: 3363864
references.citation: J Gen Virol. 2001 Sep;82(Pt 9):2095-2105
references.pmid: 11514718
references.citation: J Gen Virol. 2006 Jun;87(Pt 6):1451-1458
references.pmid: 16690909
references.citation: J Gen Virol. 1990 Nov;71 ( Pt 11):2761-7
references.pmid: 2254756
references.citation: Virology. 1990 Nov;179(1):247-66, 517-63
references.pmid: 2219722
references.citation: J Virol. 1991 Jul;65(7):3598-606
references.pmid: 2041086
references.citation: PLoS Pathog. 2008 Aug 15;4(8):e1000128
references.pmid: 18704168
references.citation: Gene. 1988 May 15;65(1):123-8
references.pmid: 2840353
references.citation: J Immunol. 1998 Aug 15;161(4):2004-10
references.pmid: 9712073
references.citation: Annu Rev Microbiol. 2003;57:323-42
references.pmid: 14527282
references.citation: J Gen Virol. 2004 Jun;85(Pt 6):1401-1412
references.pmid: 15166422
references.citation: J Gen Virol. 2006 Jan;87(Pt 1):29-38
references.pmid: 16361415
references.citation: Cell. 1992 Oct 2;71(1):145-52
references.pmid: 1339315
references.citation: J Gen Virol. 2007 Jun;88(Pt 6):1656-1666
references.pmid: 17485524
references.citation: J Immunol. 1994 Jul 15;153(2):701-11
references.pmid: 8021506
references.citation: J Virol. 2001 Jan;75(2):850-6
references.pmid: 11134298
references.citation: Nucleic Acids Res. 1990 Jul 25;18(14):4285-6
references.pmid: 2377486
references.citation: J Virol. 1988 Oct;62(10):3772-8
references.pmid: 3418784
references.citation: Gene. 1989 Apr 15;77(1):61-8
references.pmid: 2744488
references.citation: J Exp Med. 2003 Feb 3;197(3):343-51
references.pmid: 12566418
references.citation: J Immunol. 2005 Mar 15;174(6):3608-16
references.pmid: 15749898
references.citation: Chem Biol. 1997 Feb;4(2):139-47
references.pmid: 9190288
references.citation: J Gen Virol. 2002 Aug;83(Pt 8):1977-1986
references.pmid: 12124461
references.citation: J Immunol. 1998 Aug 15;161(4):1997-2003
references.pmid: 9712072
references.citation: Virology. 1994 Oct;204(1):376-90
references.pmid: 8091668
references.citation: Proc Natl Acad Sci U S A. 1985 Aug;82(16):5300-4
references.pmid: 3875097
references.citation: J Exp Med. 2005 Mar 21;201(6):1007-18
references.pmid: 15767367
references.citation: Virology. 1993 Aug;195(2):732-44
references.pmid: 8337842
references.citation: J Biol Chem. 1993 Oct 15;268(29):22100-4
references.pmid: 8408068
references.citation: Peptides. 2002 May;23(5):823-34
references.pmid: 12084512
references.citation: Annu Rev Immunol. 1998;16:27-55
references.pmid: 9597123
references.citation: J Virol. 2005 Oct;79(20):12852-60
references.pmid: 16188987
references.citation: J Virol. 2004 Apr;78(7):3553-60
references.pmid: 15016878
references.citation: Annu Rev Immunol. 2003;21:377-423
references.pmid: 12543935
references.citation: J Gen Virol. 2006 May;87(Pt 5):1157-1161
references.pmid: 16603516
references.citation: Infect Immun. 2008 Mar;76(3):942-51
references.pmid: 18086816
references.citation: J Biol Chem. 2004 Aug 27;279(35):36570-8
references.pmid: 15215253
references.citation: J Gen Virol. 2002 Dec;83(Pt 12):2915-2931
references.pmid: 12466468
references.citation: J Virol. 1996 Sep;70(9):6479-85
references.pmid: 8709286
references.citation: Nature. 1983 Apr 7;302(5908):490-5
references.pmid: 6835382
references.citation: Virology. 1991 Feb;180(2):625-32
references.pmid: 1989387